TWD 101.5
(-1.93%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 265.51 Million TWD | -17.16% |
2022 | 320.5 Million TWD | 20.67% |
2021 | 265.6 Million TWD | 35.44% |
2020 | 196.1 Million TWD | 129.45% |
2019 | 85.47 Million TWD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 241 Million TWD | -9.23% |
2024 Q2 | 241 Million TWD | 0.0% |
2023 Q4 | 265.51 Million TWD | 0.0% |
2023 FY | 265.51 Million TWD | -17.16% |
2023 Q3 | 265.51 Million TWD | -12.55% |
2023 Q1 | 303.61 Million TWD | -5.27% |
2023 Q2 | 303.61 Million TWD | 0.0% |
2022 Q3 | 320.5 Million TWD | 0.0% |
2022 FY | 320.5 Million TWD | 20.67% |
2022 Q4 | 320.5 Million TWD | 0.0% |
2021 FY | 265.6 Million TWD | 35.44% |
2020 FY | 196.1 Million TWD | 129.45% |
2019 FY | - TWD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
BIONET Corp. | 2.34 Billion TWD | 88.695% |
DIVA Laboratories, Ltd. | 1.24 Billion TWD | 78.652% |
Genetics Generation Advancement Corp. | 595.05 Million TWD | 55.38% |
Welgene Biotech Co.,Ltd. | 548.16 Million TWD | 51.563% |
TFBS Bioscience Inc. | 1.44 Billion TWD | 81.664% |